In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling

Interest has emerged in biased agonists at the mu opioid receptor (MOR) as a possible means for maintaining potent analgesis with reduced side effect profiles. While approaches measuring in vitro biased agonism are used in the development of these compounds, their therapeutic utility will ultimately...

Full description

Bibliographic Details
Main Authors: Xiao Zhang, Shaurita D. Hutchins, Bruce E. Blough, Eric J. Vallender
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/11/3999
_version_ 1797566256958668800
author Xiao Zhang
Shaurita D. Hutchins
Bruce E. Blough
Eric J. Vallender
author_facet Xiao Zhang
Shaurita D. Hutchins
Bruce E. Blough
Eric J. Vallender
author_sort Xiao Zhang
collection DOAJ
description Interest has emerged in biased agonists at the mu opioid receptor (MOR) as a possible means for maintaining potent analgesis with reduced side effect profiles. While approaches measuring in vitro biased agonism are used in the development of these compounds, their therapeutic utility will ultimately be determined by in vivo functional effects. Nonhuman primates (NHPs) are the most translational model for evaluating the behavioral effects of candidate medications, but biased signaling of these drugs at NHP MOR receptors has been unstudied. The goal of the current work was to characterize MOR ligand bias in rhesus macaques, focusing on agonists that have previously been reported to show different patterns of biased agonism in rodents and humans. Downstream signaling pathways that responded to MOR activation were identified using a luciferase reporter array. Concentration-response curves for specific pathways (cAMP, NF-ĸB, MAPK/JNK) were generated using six agonists previously reported to differ in terms of signaling bias at rodent and human MORs. Using DAMGO as a reference ligand, relative cAMP, NF-ĸB and MAPK/JNK signaling by morphine, endomorphin-1, and TRV130 were found to be comparable between species. Further, the bias patterns of across ligands for NF-ĸB and MAPK/JNK were largely similar between species. There was a high degree of concordance between rhesus macaque and human MOR receptor signaling bias for all agonists tested, further demonstrating their utility for future translational behavioral studies.
first_indexed 2024-03-10T19:24:10Z
format Article
id doaj.art-ca079b9a90c3493bb08d5d52a1c63fa1
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T19:24:10Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ca079b9a90c3493bb08d5d52a1c63fa12023-11-20T02:45:31ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-06-012111399910.3390/ijms21113999In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream SignalingXiao Zhang0Shaurita D. Hutchins1Bruce E. Blough2Eric J. Vallender3Program in Neuroscience, University of Mississippi Medical Center, Jackson, MS 39216, USADepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216, USACenter for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC 27709, USAProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS 39216, USAInterest has emerged in biased agonists at the mu opioid receptor (MOR) as a possible means for maintaining potent analgesis with reduced side effect profiles. While approaches measuring in vitro biased agonism are used in the development of these compounds, their therapeutic utility will ultimately be determined by in vivo functional effects. Nonhuman primates (NHPs) are the most translational model for evaluating the behavioral effects of candidate medications, but biased signaling of these drugs at NHP MOR receptors has been unstudied. The goal of the current work was to characterize MOR ligand bias in rhesus macaques, focusing on agonists that have previously been reported to show different patterns of biased agonism in rodents and humans. Downstream signaling pathways that responded to MOR activation were identified using a luciferase reporter array. Concentration-response curves for specific pathways (cAMP, NF-ĸB, MAPK/JNK) were generated using six agonists previously reported to differ in terms of signaling bias at rodent and human MORs. Using DAMGO as a reference ligand, relative cAMP, NF-ĸB and MAPK/JNK signaling by morphine, endomorphin-1, and TRV130 were found to be comparable between species. Further, the bias patterns of across ligands for NF-ĸB and MAPK/JNK were largely similar between species. There was a high degree of concordance between rhesus macaque and human MOR receptor signaling bias for all agonists tested, further demonstrating their utility for future translational behavioral studies.https://www.mdpi.com/1422-0067/21/11/3999opioidbiased agonismmorphinenonhuman primatesecond messenger signaling
spellingShingle Xiao Zhang
Shaurita D. Hutchins
Bruce E. Blough
Eric J. Vallender
In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
International Journal of Molecular Sciences
opioid
biased agonism
morphine
nonhuman primate
second messenger signaling
title In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
title_full In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
title_fullStr In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
title_full_unstemmed In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
title_short In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
title_sort in vitro effects of ligand bias on primate mu opioid receptor downstream signaling
topic opioid
biased agonism
morphine
nonhuman primate
second messenger signaling
url https://www.mdpi.com/1422-0067/21/11/3999
work_keys_str_mv AT xiaozhang invitroeffectsofligandbiasonprimatemuopioidreceptordownstreamsignaling
AT shauritadhutchins invitroeffectsofligandbiasonprimatemuopioidreceptordownstreamsignaling
AT bruceeblough invitroeffectsofligandbiasonprimatemuopioidreceptordownstreamsignaling
AT ericjvallender invitroeffectsofligandbiasonprimatemuopioidreceptordownstreamsignaling